Oximidine III

Oximidine III is an anti-tumor antibiotic. Oximidine III can selectively inhibit the growth of 3Y1 in rat fibroblasts with degeneration of various tumor genes. Oximidine III inhibits v-H-ras-3Y1, v-src-3Y1 cells and the normal 3Y1 cells with IC50s (nM) of 14, 4.5 and 140, respectively. Oximidine III stops RAS-or SRC-denatured cells at G1 phase of the cell cycle and increases p21WAF1 expression[1].

Product Specifications

CAS Number

[664365-72-4]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Field of Research

Cancer; Infection

Smiles

CO/N=C/C=C\C(N/C=C/C[C@H]1C[C@@]2([H])[C@](/C=C\C=C\C3=CC=CC(O)=C3C(O1)=O)([H])O2)=O

Molecular Formula

C23H24N2O6

Molecular Weight

424.45

References & Citations

[1]Eveline Vriens, et al. Polyketide Synthase-Mediated O-Methyloxime Formation in the Biosynthesis of the Oximidine Anticancer Agents. Angew Chem Int Ed Engl. 2023 Aug 21;62 (34) :e202304476.